The Cytel Blog: Perspectives on Enquiry & Evidence

Real world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is..

Data is the most crucial asset of any clinical trial and hence, sponsors cannot jeopardize collecting clean..

Adopting data standards such as CDISC in the early phase of clinical drug development contributes to the consolidation..

Data is the cornerstone of any clinical trial and is used to ultimately drive the decision-making process related to..

Single arm trials are emerging as an accepted way of assessing a new treatment intervention. They establish clinical..

Just as there are numerous adaptations that fall within the umbrella of adaptive designs, there are several different..

Cytel scientists recently published a new eBook on synthetic control arms and a new scientific primer for the more..

Cytel has recently published a new ebook on synthetic control arms, and a new scientific primer as well.

Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the..